Ozenoxacin

奥泽沙星

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NameOzenoxacin
Drug Alias Nameozenoxacinum奥珍沙星ozenoxacinoXepiZebiax +[11] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsRosaceaAcne VulgarisSkin Diseases, Infectious +[4] 
Global Approved IndicationsAcne VulgarisSkin Diseases, InfectiousImpetigo
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoEU +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesToyama Chemical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPelthos Therapeutics IncFerrer Internacional SaMaruho Co Ltd +[4] 
Inactive CompaniesLnhc Inc
Active IndicationsRosaceaAcne VulgarisSkin Diseases, Infectious
Inactive IndicationsImpetigo

Other Information

ATC CodeD06AX14
Related LinksWikipediaDrugBankKEGG